Elevated levels of C-reactive protein (CRP) have been demonstrated in CAVD but have not been shown to correlate with disease severity or progression in larger observational trials (54–56). The gene discussed is CRP; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.